Details of the Drug Reposition

General Information of This Drug (ID: DMGUHYW)

Drug Name
NI-0501   DMGUHYW
Synonyms Anti-IFN gamma antibody, NovImmune/Merck Serono; Anti-IFN gamma antibody, NovImmune/Serono; Anti-interferon gamma antibody, NovImmune/Merck Serono; Anti-interferon gamma antibody, NovImmune/Serono

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Primary haemophagocytic lymphohistiocytosis DISHFGBE 4A01.23 Phase 2 [1]
Autoimmune diabetes DISW6UF1 5A10 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT01818492) A Study to Investigate the Safety and Efficacy of an Anti-IFN mAb in Children Affected by Primary Haemophagocytic Lymphohistiocytosis. U.S. National Institutes of Health.